Tenofovir

allAfrica: African news and information for a global audienceMylan Inc.'s subsidiary, Matrix Laboratories received final approval from the FDA for its Abbreviated New Drug Application for Lansoprazole Delayed-release. The feed you requested is currently unavailable. Technorati has retired all of the legacy feeds and is in the process of creating new ones based on our new infrastructure. The following new feeds are available now: Hottest Blogosphere Posts Latest Original Articles from Technorati The Technorati Blog

IP Overview HIV Therapy 2009” establishes a panorama of the patents claiming “HIV and AIDS treatments” and analyses the key and emerging thematic and the strategic positions of the actors involved in this sector. In order to fully analyze this field, the information coming from 6800 published ...Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration has approved a labeling update for REYATAZ® to include long-term data from the CASTLE Study.Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has approved a labeling update for REYATAZ ® to include long-term data from the CASTLE Study.Your dark locks could hold the key to a breakthrough in HIV prevention.Wanted: Dark-haired HIV-negative men and women to participate in a study designed to measure drug levels in hair. It's called the "Strand Study" and it's part of a larger effort by AIDS scientists to look at whether people who are HIV-negative can benefit...Although HIV-positive women had lower bone mineral density in the lower spine and neck on entry to the study, they had similar rates of bone loss during follow-up. Moreover, HIV treatment was not a risk factor for bone loss.